Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Roche Holding Div RTS (RHHVF)

Roche Holding Div RTS (RHHVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools

BASEL, Switzerland , March 5, 2026 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today findings from a global survey of 4,326 people with diabetes across 22 countries, exploring the...

RHHVF : 392.8877 (+0.74%)
ROG : 105.68 (-3.34%)
RHHBY : 48.6840 (+0.77%)
Roche Holding AG (RHHVF) Gets a Buy from DZ BANK AG

DZ BANK AG analyst Elmar Kraus maintained a Buy rating on Roche Holding AG today. The company’s shares closed yesterday at $351.28.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

RHHVF : 392.8877 (+0.74%)
RHHBY : 48.6840 (+0.77%)
CHRO : 1.3500 (+7.14%)
UBS Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

In a report released today, Matthew Weston from UBS maintained a Buy rating on Roche Holding AG, with a price target of CHF314.00. The company’s shares closed last Friday at $357.00.Elevate Your Investing...

RHHVF : 392.8877 (+0.74%)
RHHBY : 48.6840 (+0.77%)
CHRO : 1.3500 (+7.14%)
J.P. Morgan Sticks to Their Sell Rating for Roche Holding AG (RHHVF)

In a report released today, Richard Vosser from J.P. Morgan maintained a Sell rating on Roche Holding AG, with a price target of CHF230.00. The company’s shares closed last Friday at $357.00.Elevate...

RHHVF : 392.8877 (+0.74%)
RHHBY : 48.6840 (+0.77%)
CHRO : 1.3500 (+7.14%)
Roche Holding AG (RHHVF) Receives a Hold from Barclays

In a report released today, Yihan Li from Barclays maintained a Hold rating on Roche Holding AG, with a price target of CHF275.00. The company’s shares closed yesterday at $362.85.Elevate Your Investing...

RHHVF : 392.8877 (+0.74%)
RHHBY : 48.6840 (+0.77%)
CHRO : 1.3500 (+7.14%)
J.P. Morgan Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG today and set a price target of CHF230.00. The company’s shares opened today at $360.22.Elevate Your Investing Strategy:...

RHHVF : 392.8877 (+0.74%)
RHHBY : 48.6840 (+0.77%)
CHRO : 1.3500 (+7.14%)
Goldman Sachs Remains a Sell on Roche Holding AG (RHHVF)

Goldman Sachs analyst Rajan Sharma maintained a Sell rating on Roche Holding AG today and set a price target of CHF248.00. The company’s shares closed last Friday at $360.15.Elevate Your Investing Strategy:...

RHHVF : 392.8877 (+0.74%)
RHHBY : 48.6840 (+0.77%)
CHRO : 1.3500 (+7.14%)
HSBC upgrades Roche Holding AG (RHHVF) to a Buy

In a report released yesterday, Rajesh Kumar from HSBC upgraded Roche Holding AG to a Buy, with a price target of CHF320.00. The company’s shares closed yesterday at $353.22.Elevate Your Investing Strategy:...

RHHVF : 392.8877 (+0.74%)
RHHBY : 48.6840 (+0.77%)
CHRO : 1.3500 (+7.14%)
Biotechs Big Bang: IPOs, Uplists and the Short Squeeze Effect

When a microcap %Biotech transitions from obscurity to the Nasdaq Capital Market, fireworks are common. The move often signals a pivotal moment in the company's growth trajectory, opening the door to broader...

SANA : 2.67 (-3.61%)
RHHVF : 392.8877 (+0.74%)
$SANA : 3,452.65 (+8.59%)
PPCB : 0.1060 (+2.71%)
MRNA : 47.90 (-3.35%)

Barchart Exclusives

Amazon Just Lost a Key AI Chip Executive. Is That Bad News for AMZN Stock?
With key leaders stepping away from Amazon’s AI team, is the online retail giant simply evolving, or is it a potential red flag investors shouldn’t ignore? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.